Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123
2023 · Nature Biotechnology · 98 citations
https://doi.org/10.1038/s41587-022-01626-2
A
Anne-Laure Bauchet
Sanofi (France)(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
657
Citations
10
h-index
10
i10-index
Anne-Laure Bauchet is an academic researcher from Sanofi (France). The author has contributed to research in topics: Immune cells in cancer & Cancer Research and Treatments & Immunotherapy and Immune Responses. The author has an h-index of 10, co-authored 46 publications.
Papers by this author
worksInduction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund’s Adjuvant in Three Non-human Primate Species
2013 · Journal of Neuroimmune Pharmacology · 54 citations
https://doi.org/10.1007/s11481-013-9487-z
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer
2022 · Nature Communications · 51 citations
https://doi.org/10.1038/s41467-022-31668-8
Biomarker analysis from a Phase 1/1b study of tusamitamab ravtansine in patients with advanced non-small cell lung cancer
2025 · Translational Oncology · 1 citations
https://doi.org/10.1016/j.tranon.2025.102615
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat